UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2009-05, Vol.136 (5), p.1561-1567

2009

Volltextzugriff (PDF)

Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis

Scandinavian journal of gastroenterology, 2016-05, Vol.51 (5), p.556-562

2016

Volltextzugriff (PDF)

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

Gastroenterology (New York, N.Y. 1943), 2001-05, Vol.120 (6), p.1356-1362

2001

Volltextzugriff (PDF)

Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males

Gastroenterology (New York, N.Y. 1943), 2010-05, Vol.138 (5), p.1697-1703.e2

2010

Volltextzugriff (PDF)

Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity

Inflammatory bowel diseases, 2013-02, Vol.19 (2), p.283-292

2013

Volltextzugriff (PDF)

Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2016-05, Vol.10 (5), p.556-565

2016

Volltextzugriff (PDF)

Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients

Gastroenterology (New York, N.Y. 1943), 1998-06, Vol.114 (6), p.1151-1160

1998

Volltextzugriff (PDF)

Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial

Journal of Crohn's and colitis, 2013-02, Vol.7 (1), p.34-43

2013

Volltextzugriff (PDF)

A Randomized, Double-Blind, Sham-Controlled Study of Granulocyte/Monocyte Apheresis for Active Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2008-08, Vol.135 (2), p.400-409

2008

Volltextzugriff (PDF)

Group‐based intervention program in inflammatory bowel disease patients: Effects on quality of life

Inflammatory bowel diseases, 2007-02, Vol.13 (2), p.182-190

2007

Volltextzugriff (PDF)

Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission : A predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials

The American journal of gastroenterology, 2005-08, Vol.100 (8), p.1780-1787

2005

Volltextzugriff (PDF)

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?

The American journal of gastroenterology, 2011-02, Vol.106 (2), p.199-212

2011

Volltextzugriff (PDF)

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE

Inflammatory bowel diseases, 2012-01, Vol.18 (1), p.1-9

2012

Volltextzugriff (PDF)

Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis

European journal of gastroenterology & hepatology, 1998-10, Vol.10 (10), p.831-836

1998

Volltextzugriff (PDF)

Colitis‐associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer

Inflammatory bowel diseases, 2011-05, Vol.17 (5), p.1101-1107

2011

Volltextzugriff (PDF)

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1294-1302

2016

Volltextzugriff (PDF)

HLA Associations Distinguish Collagenous From Lymphocytic Colitis

The American journal of gastroenterology, 2016-08, Vol.111 (8), p.1211-1213

2016

Volltextzugriff (PDF)

Long-term histomorphological surveillance of the pelvic ileal pouch: Dysplasia develops in a subgroup of patients

Gastroenterology (New York, N.Y. 1943), 1995-10, Vol.109 (4), p.1090-1097

1995

Volltextzugriff (PDF)

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies

Journal of Crohn's and colitis, 2019-05, Vol.13 (6), p.725-734

2019

Volltextzugriff (PDF)

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

Gastroenterology (New York, N.Y. 1943), 2002-02, Vol.122 (2), p.512-530

2002

Volltextzugriff (PDF)

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study

European journal of gastroenterology & hepatology, 2016-11, Vol.28 (11), p.1320-1328

2016

Volltextzugriff (PDF)

Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity

Inflammatory bowel diseases, 2002-07, Vol.8 (4), p.258-263

2002

Volltextzugriff (PDF)

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

Advances in therapy, 2018-04, Vol.35 (4), p.563-576

2018

Volltextzugriff (PDF)

1 – 25 von 167

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Englisch
(161)
Schwedisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(100)
Life Sciences & Biomedicine
(94)
Humans
(83)
Medicin Och Hälsovetenskap
(72)
Gastroenterology & Hepatology
(59)
Female
(57)
Male
(55)
Adult
(52)
Middle Aged
(40)
Biological And Medical Sciences
(34)
Medical Sciences
(33)
Adolescent
(27)
Aged
(26)
Gastroenterology And Hepatology
(25)
Risk Factors
(24)
Ulcerative Colitis
(23)
Gastroenterology. Liver. Pancreas. Abdomen
(19)
Inflammatory Bowel Disease
(19)
Child
(17)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease

Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males

Topical treatment with the Toll-like receptor agonist DIMS0150 has potential for lasting relief of symptoms in patients with chronic active ulcerative colitis by restoring glucocorticoid sensitivity

Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease

Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients

Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial

A Randomized, Double-Blind, Sham-Controlled Study of Granulocyte/Monocyte Apheresis for Active Ulcerative Colitis

Group‐based intervention program in inflammatory bowel disease patients: Effects on quality of life

Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission : A predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?

Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE

Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis

Colitis‐associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis

HLA Associations Distinguish Collagenous From Lymphocytic Colitis

Long-term histomorphological surveillance of the pelvic ileal pouch: Dysplasia develops in a subgroup of patients

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study

Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

Suchergebnisse filtern